1 year return (CAGR)
-98.81%
Gamida Cell Ltd Exchange (NASDAQ, USD)
GMDA
-
+0.00 (+2.22%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-86.72%
5 year return (CAGR)
-70.65%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.44M
Price/Sales
0.91
Ent value
75.95M
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-23.06%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.02 |
| Daily high | 0.02 |
| Daily low | 0.02 |
| Daily Volume | 596K |
| 1y analyst estimate | 4.00 |
| Beta | 1.03 |
| EPS (TTM) | -0.14 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GMDA | S&P500 | |
| Current price drop from All-time high | -99.88% | -2.85% |
| Highest price drop | -99.94% | -56.47% |
| Date of highest drop | 12 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -71.41% | -10.68% |
| Avg time to new high | 198 days | 12 days |
| Max time to new high | 1359 days | 1805 days |
News
No items found